covid-19-disease

Documents about covid-19-disease

• Role of biochemical markers in the monitoring of covid-19 patients#935970Repositorio de Universidad Autónoma de Chile.
• Factors associated with COVID-19-related death using OpenSAFELY#7242OpenAlex
• Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)#162559ClinicalTrials.gov
• Association Between Initial Symptoms and Clinical Outcomes in COVID-19#455579OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19#825673ClinicalTrials.gov
• Post COVID-19 Functional Status in Egypt#851754ClinicalTrials.gov
• COVID-19 Testing Pilot Study#899417ClinicalTrials.gov
• Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.#329703Dipòsit Digital de la Universitat de Barcelona
• Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)#857804ClinicalTrials.gov
• Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment#905269ClinicalTrials.gov
• COVID-19: 20 countries’ higher education intra-period digital pedagogy responses#10560OpenAlex
• <scp>COVID</scp>‐19 pandemic cybersecurity issues#199700OpenAlex
• COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study#829703ClinicalTrials.gov
• Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection#884532ClinicalTrials.gov
• Effectiveness of Modified Diaphragmatic Training for Gastroesophageal Reflux Disease Post Covid-19#883319ClinicalTrials.gov
• Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia#908591ClinicalTrials.gov
• Invasive meningococcal disease rebound in older adults post-COVID-19 pandemic: A targeted literature and surveillance review#189702IRIS
• Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 13 January 2023#413789WHO IRIS
• Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients#896640ClinicalTrials.gov
• Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19)#911891ClinicalTrials.gov
• Sustaining essential healthcare in Africa during the COVID-19 pandemic#379377University of Pretoria Repository
• COVID-19: Human Epidemiology and Response to SARS-CoV-2#897864ClinicalTrials.gov
• Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19#905930ClinicalTrials.gov
• A Survey of COVID-19 Contact Tracing Apps#199585OpenAlex
• Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23#424247ClinicalTrials.gov
• The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease#845697ClinicalTrials.gov
• Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)#880883ClinicalTrials.gov
• Outcomes of Obstetric Patients With COVID-19 Disease in the ICU#910404ClinicalTrials.gov
• Coordinating Coronavirus Research: The COVID-19 Infectious Disease Ontology#81273PhilArchive
• Lesson from COVID-19 diagnosis and infectious disease prevention for future#765156PhilArchive
• Revue intra-action (RIA) de la COVID-19 : modèle de note conceptuelle, 23 juillet 2020#649871WHO IRIS
• TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation#1031956ClinicalTrials.gov
• The Containing Coronavirus Disease 19 (COVID-19) Trial#838651ClinicalTrials.gov
• Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic#807054ClinicalTrials.gov
• Impact of the Lockdown Due to the COVID Pandemic in French Wilson's Disease Patients#828236ClinicalTrials.gov
• COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience#148605ClinicalTrials.gov
• Clinical management of COVID-19: living guideline, June 2025#663617WHO IRIS
• Impact of COVID-19 Pandemic: A Cybersecurity Perspective#671945OpenAlex
• Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia#830384ClinicalTrials.gov
• Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19#857729ClinicalTrials.gov
• Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study#865225ClinicalTrials.gov
• Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19#866121ClinicalTrials.gov
• Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19#871364ClinicalTrials.gov
• A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)#896896ClinicalTrials.gov
• Artificial Intelligence for COVID-19: Rapid Review#964530OpenAlex
• Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients#967746ClinicalTrials.gov
• Sleep Quality in Healthcare Personnel During COVID-19#980054ClinicalTrials.gov
• The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19#991926ClinicalTrials.gov
• Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)#891750ClinicalTrials.gov
• Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)#915740ClinicalTrials.gov